(Updates with the company's underwritten public offering in the seventh and eighth paragraphs.)

Alignment Healthcare (ALHC) posted a Q4 loss late Thursday of $0.05 per diluted share, narrowing from the loss of $0.16 a year earlier.

Analysts polled by FactSet expected a loss of $0.15.

Revenue for the quarter ended Dec. 31 rose to $1.01 billion from $701.2 million a year earlier.

Analysts surveyed by FactSet expected $1 billion.

The company expects revenue of $1.21 billion to $1.23 billion in Q1 and $5.14 billion to $5.19 billion in the full year.

Analysts expect $1.24 billion in Q1 and $5.21 billion in the full year.

Alignment said that an affiliate of General Atlantic will sell roughly 13.2 million shares of its common stock through an underwritten public offering, and that it will not receive proceeds from the sale.

The sale is being made pursuant to a Form S-3 shelf registration statement, which has become effective immediately upon filing with the SEC on March 2, the company said.